Healthia shares halted on $15m cap raise and acquisition spree

This small-cap healthcare share is continuing its acquisitive streak.

| More on:
Female doctor with a mask holds out hand in a stop gesture.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Healthia shares are stuck in a trading halt today
  • The company is undertaking a $15 million capital raising
  • Healthia has announced its first three acquisitions for FY23

The Healthia Ltd (ASX: HLA) share price isn't going anywhere this morning as shares have been placed in a trading halt.

The ASX healthcare share has announced a $15 million capital raising to fund acquisition opportunities and provide additional financial flexibility.

Healthia taps the market

Healthia intends to raise up to $10 million from institutional shareholders and up to $5 million from retail shareholders.

The institutional component is partially underwritten by Canaccord.

Retail shareholders will be entitled to subscribe for one new share for every 12.5 Healthia shares they hold at 7pm on Monday, 12 September.

New shares are being offered at an issue price of $1.47, representing a 3.3% discount from the last Healthia closing price of $1.52.

The capital raising will result in roughly 10.3 million new Healthia shares being issued, equating to around 8% of the company's current share count.

Following the capital raising and on a pro forma basis as of 30 June 2022, Healthia would have total liquidity of roughly $36.2 million.

Acquisitions ahoy

Healthia was extremely busy on the M&A front in FY22, spending $111.3 million on acquisitions to increase its portfolio from 212 to 307 businesses.

This acquisitive streak is set to continue.

In today's announcement, the company noted it has a large active pipeline of potential allied health acquisition opportunities. It's reviewing more than 110 allied health businesses as potential targets.

As a result, it is confident in being able to deploy at least $20 million to acquisitions in FY23.

To kick things off, Healthia has entered into three separate binding agreements to acquire 12 physiotherapy clinics.

It will be acquiring Watsonia Physiotherapy, a single clinic operating in Victoria.

Corio Bay Health Group will also join the fold. Its nine allied health businesses in Victoria will soon fall under the Healthia banner.

Finally, as already announced in June, the company will also acquire Sunshine Coast Hand Therapy, which comprises two clinics.

Healthia anticipates paying $8.29 million of total consideration for these acquisitions. This will comprise upfront cash of $6.61 million and the issuance of clinic class shares worth $1.68 million.

The company expects these acquisitions to contribute annualised revenue of $8.88 million and annualised EBITDA of $1.87 million.

Healthia also expects these acquisitions will be immediately earnings accretive. 

What's more, any earnings from acquisitions settled in FY23 will be in addition to the $40 million EBITDA guidance.

Healthia share price snapshot

The Healthia share price has tumbled 34% in the year to date. Over the last 12 months, Healthia shares are printing a 20% fall.

Healthia currently has a market capitalisation of $195 million.

The company requested today's trading halt until it makes an announcement regarding the outcome of the institutional component of the capital raising. 

At the latest, Healthia shares will resume trading on Monday.

Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended HEALTHIA FPO. The Motley Fool Australia has recommended HEALTHIA FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

three excited doctors with hands in the air
Healthcare Shares

Why Macquarie forecasts a 22% upside for this ASX All Ords healthcare stock

Macquarie expects a big rebound ahead for this ASX healthcare stock. But why?

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Healthcare Shares

Guess which ASX All Ords stock is jumping 9% on $1.6b market opportunity

This small cap is having a big day. But why?

Read more »

A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
Healthcare Shares

75% upside: Broker tips two ASX healthcare shares

This broker sees big potential in these two Australian healthcare companies 

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

What does the Macquarie Hospital Claims Index mean for ASX 200 health insurance stocks?

Macquarie shares its view on Medibank Private and NIB Holdings.

Read more »

Two lab workers fist pump each other.
Broker Notes

What's JP Morgan's price target on CSL shares?

Are CSL shares undervalued or will they continue to underperform?

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

2 ASX healthcare stocks making huge moves on big news

These shares are getting investors excited today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Which ASX All Ords stock is up 15% on guidance upgrade?

Let's find out what is getting investors excited on Tuesday.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

3 reasons why the Sigma Healthcare share price could be a buy

This business has a very exciting outlook.

Read more »